Quantcast
Last updated on April 24, 2014 at 17:35 EDT

Latest Hot flash Stories

Hypnosis May Help Reduce Hot Flashes
2012-11-01 10:58:26

Connie K. Ho for redOrbit.com — Your Universe Online While some people believe that hypnosis is just for fun and games, new research reports that clinical hypnosis is effective in helping menopausal females. A new study by scientists at Baylor University´s Mind-Body Medicine Research Laboratory recently revealed that clinical hypnosis can help decrease the occurrence of hot flashes and other related symptoms following menopause for women. The scientists tracked the physical...

2012-10-24 23:44:01

Hypnosis can help cut hot flashes by as much as 74%, shows a study supported by the National Center for Complementary and Alternative Medicine. This is the first controlled, randomized study of the technique to manage hot flashes, which affect as much as 80% of women who go through menopause. The study was published online this month in Menopause, the journal of the North American Menopause Society. Controlled, randomized studies may pit an active drug against an inactive placebo pill. But...

2012-10-15 07:28:58

MENLO PARK, Calif., Oct. 15, 2012 /PRNewswire/ -- Depomed, Inc. (Nasdaq: DEPO) today announced that its New Drug Application (NDA) for Serada® has been accepted for filing by the U.S. Food and Drug Administration (FDA). In addition, the FDA has informed the company that the FDA's Reproductive Health Drugs Advisory Committee will discuss the Serada NDA at an Advisory Committee meeting tentatively scheduled for March 4, 2013. The NDA will be subject to a standard review and will have a...

Hormone Therapy Could Reduce Heart Attack Risk
2012-10-10 18:16:58

Lee Rannals for redOrbit.com - Your Universe Online According to a study published in the journal BMJ, taking hormone replacement therapy (HRT) may reduce the risk of developing heart problems. The researchers found that HRT is not associated with an increased risk of cancer or stroke as several previous studies have claimed, and it also may help reduce the risk of heart attacks. The team followed 1,000 women over 10 years, half of which were on HRTs. Women who took part in the study...

2012-10-07 23:03:28

Joy Behar, of The View, Reviews Hot Girls Pearls on OpenSky.com on October 7th. New York, NY (PRWEB) October 06, 2012 Online shoppers and cool accessory lovers: be sure to tune in to hot social media e-commerce site OpenSky.com (https://opensky.com/joybehar) on October 7th and thereafter. The View co-host and OpenSky.com celebrity curator Joy Behar will be reviewing and recommending HOT GIRLS PEARLS, the first-of-its-kind high-fashion frozen jewelry. HOT GIRLS PEARLS, a collection of...

2012-10-03 10:24:12

PHOENIX, Oct. 3, 2012 /PRNewswire-USNewswire/ -- Estrogen/progesterone treatment started soon after menopause appears safe and relieves many of the symptoms menopausal women face as well as improving mood and markers of cardiovascular risk, according to a multicenter randomized study presented at the North American Menopause Society (NAMS) Annual Meeting in Orlando, Florida. "The KEEPS provides invaluable information for women close to menopause and their clinicians," said S. Mitchell...

2012-10-03 02:27:32

MENLO PARK, Calif., Oct. 3, 2012 /PRNewswire/ -- Depomed, Inc. (NASDAQ: DEPO) announced today that it is presenting two abstracts from its Phase 3 clinical trial, BREEZE 3, at this week's 23(rd) Annual Meeting of the North American Menopause Society (NAMS) in Orlando, FL. The data showed that Serada(®), Depomed's investigational non-hormonal extended-release formulation of gabapentin, may help manage menopausal hot flashes. "Hot flashes are a disruptive problem affecting as many as...

2012-10-02 18:22:15

MIAMI, FL, NEW YORK, NY and ORLANDO, FL, Oct. 3, 2012 /PRNewswire/ -- Noven Pharmaceuticals, Inc., a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today announced positive results from two multicenter, double-blind, randomized, placebo-controlled Phase 3 clinical studies evaluating low-dose mesylate salt of paroxetine (LDMP; 7.5 mg/day) for the treatment of moderate to severe vasomotor symptoms (VMS) associated with menopause. Menopausal VMS, which comprise hot flashes...

2012-10-01 02:32:37

CROMWELL, Conn., Oct. 1, 2012 /PRNewswire/ -- Every three minutes, a woman is diagnosed with breast cancer in this country, creating an abundant need to do more to find a cure.+ Estroven, the safe multi-symptom menopause relief solution, is inviting women across the country to band together during National Breast Cancer Awareness Month by "Sleeping Pink" - hosting pink-themed parties - to raise much-needed funds for the Avon Walk for Breast Cancer series, a project of the Avon Foundation for...

2012-10-01 02:31:36

SANTA FE, N.M., Oct. 1, 2012 /PRNewswire/ -- This story is a comparative analysis of the untold story of certain botanicals for Menopause, what risks they suggest, but most importantly, what the sellers are not telling women about the risks when they take these botanicals for Menopause, and not explaining why these ingredients do not have warning labels. Menopause affects 45 million women annually. Huge numbers! The story launched into the public four weeks ago via www.SafeMenopause.com. A...